SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,889,000 | -3.1% | 25,039 | -4.1% | 0.06% | +19.6% |
| Q4 2019 | $2,982,000 | +49.0% | 26,098 | +11.3% | 0.05% | +34.2% |
| Q3 2019 | $2,002,000 | +26.9% | 23,442 | +2.9% | 0.04% | +18.8% |
| Q2 2019 | $1,577,000 | +6.9% | 22,786 | +13.1% | 0.03% | -3.0% |
| Q1 2019 | $1,475,000 | +25.6% | 20,140 | -2.8% | 0.03% | +10.0% |
| Q4 2018 | $1,174,000 | +7.0% | 20,723 | +45.7% | 0.03% | +87.5% |
| Q3 2018 | $1,097,000 | +12.2% | 14,223 | -3.5% | 0.02% | -23.8% |
| Q2 2018 | $978,000 | +26.8% | 14,737 | 0.0% | 0.02% | +23.5% |
| Q1 2018 | $771,000 | +4.2% | 14,737 | +6.5% | 0.02% | +88.9% |
| Q4 2017 | $740,000 | +3.1% | 13,841 | +4.9% | 0.01% | -18.2% |
| Q3 2017 | $718,000 | +5.3% | 13,189 | 0.0% | 0.01% | -47.6% |
| Q2 2017 | $682,000 | -21.1% | 13,189 | -4.0% | 0.02% | -22.2% |
| Q1 2017 | $864,000 | +30.9% | 13,742 | +9.8% | 0.03% | +17.4% |
| Q4 2016 | $660,000 | – | 12,516 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |